Stay updated on Pembrolizumab and Acalabrutinib in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab and Acalabrutinib in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab and Acalabrutinib in NSCLC Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    The page’s Revision tag was updated from v3.6.5 to v3.6.6, signaling a new version of the page content or its underlying template.
    Difference
    0.1%
    Check dated 2026-08-29T20:58:22.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    40 days ago
    Change Detected
    Summary
    The page now presents an error page indicating the content is unavailable, including the HTML skeleton and header/footer, which removes the study information and linked documents from view.
    Difference
    16%
    Check dated 2026-08-08T17:46:50.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.3 to v3.6.4, indicating a minor system update; no study details or visible content were altered.
    Difference
    0.1%
    Check dated 2026-07-25T10:51:35.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    Revision updated from v3.6.2 to v3.6.3, indicating a new site build. This change appears to be a minor platform update and does not reflect changes to the study content on this page.
    Difference
    0.1%
    Check dated 2026-07-03T21:53:33.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    The site software revision was updated from v3.6.0 to v3.6.2, indicating a minor release. No changes to the study details or visible page content are introduced.
    Difference
    0.1%
    Check dated 2026-06-26T19:49:16.000Z thumbnail image
  9. Check
    97 days ago
    Change Detected
    Summary
    The page now indicates that recruitment is closed and adds new help/navigation sections. The Intervention/Treatment label is updated, and the revision footer shows v3.6.0 compared to v3.5.5.
    Difference
    0.5%
    Check dated 2026-06-12T16:20:16.000Z thumbnail image

Stay in the know with updates to Pembrolizumab and Acalabrutinib in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Acalabrutinib in NSCLC Clinical Trial page.